CANbridge Life Sciences
2012
FOUNDED
PRIVATE
STATUS
Series B
LATEST DEAL TYPE
$25M
LATEST DEAL AMOUNT
7
INVESTORS
Description
Developer of specialty healthcare products designed to treat critical medical conditions. The company's specialty healthcare products prevent and treat high-profile oral mucositis, breast cancer, genetic diseases, and other chronic diseases, enabling patients to access improved treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- Suite 301, 3F, Timeloit
- Number 17 RongChuang Road, Chaoyang District
- Beijing, 100102
- China
+86 010 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore CANbridge Life Sciences’s full profile, request a free trial.
CANbridge Life Sciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 21-Feb-2017 | $25M | 000.00 | 0000 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A2) | 01-Nov-2015 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A1) | 01-Dec-2014 | $5M | $6.14M | 0000 | Completed | Generating Revenue |
| 1. Angel (individual) | 06-Jun-2013 | $1.14M | $1.14M | Completed | Startup |
CANbridge Life Sciences Competitors (42)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abbisko Therapeutics | Venture Capital-Backed | Shanghai, China | 00000 | 00000000000 | 00000 | |
| 0000 0000000000 | Venture Capital-Backed | Beijing, China | 0000 | 0000000000 0 | 0000 | |
| 000000000 00000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 00000000 | 00000 |
| 0000 00000000000 | Venture Capital-Backed | Shanghai, China | 00000 | 00000000000 | 00000 | |
| 0000000 | Formerly PE-Backed | Beijing, China | 0000 | 00.000 | 000000000 | 00.000 |
CANbridge Life Sciences Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| AppTec Laboratory Services | Corporation | Minority | 000 0000 | 000000 0 | ||
| Biossom Investment Management | Other | Minority | 000 0000 | 000000 0 | ||
| Lapam Capital | Other | Minority | 000 0000 | 000000 0 | ||
| Yanyuan Capital | Other | Minority | 000 0000 | 000000 0 | ||
| YuanMing Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
CANbridge Life Sciences Executive Team (11)
5 Former Executives
You’re viewing 5 of 11 executives. Get the full list »CANbridge Life Sciences Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Xue Ph.D | CANbridge Life Sciences | Founder, Chief Executive Officer and Chairman | 000 0000 | |
| William Hu | Qiming Venture Partners | Board Member | 000 0000 |